BioSpace News Archive

Rx3000® UV-C Light, HEPA filtration combination inactivates and traps 99.9% of airborne viruses, bacteria, mold, fungi and particulates

Data From CENTAUR Trial Published in Muscle & Nerve Demonstrates That Administration of AMX0035 Results in Longer Survival for People With ALS Early Administration of AMX0035 Reduced the Risk of Death by 44% Over the Duration of Follow-Up AMX0035 is the First ALS Therapeutic to Demonstrate Both a Statistically Significant Survival and Functional Benefit in ALS in a Randomized Controlled Trial

Cellectis S.A. announced that its majority-owned subsidiary Calyxt, Inc., a plant-based technology company, has entered into definitive agreements with institutional investors for the purchase and sale of 3,750,000 shares of Calyxt’s common stock, at a purchase price of $4.00 per share, in a registered direct offering.

Selexis SA , a JSR Life Sciences Company, today announced the appointment of Dirk Lange to Chief Executive Officer (CEO). Mr. Lange succeeds the company’s founding CEO, Dr. Igor Fisch, who had led the company since he co-founded it in 2001 and is departing to pursue other opportunities. As new Selexis CEO, Mr. Lange will help advance the continued market adoption of Selexis’ cell line development technologies and oversee th

FORTUNE and Great Place to Work ® Name Horizon Therapeutics plc to Best Medium Workplaces List for Fifth Consecutive Year

Visage Imaging, Inc., a wholly owned subsidiary of Pro Medicus Ltd., has announced the signing of Munich-based Ludwig-Maximilians-Universität, one of the largest university hospitals in Europe.

Aquarius Surgical Technologies, Inc is pleased to announce that John Bulicek has joined its business development team, as Vice President.

Coherus BioSciences, Inc., announced that effective October 15, 2020, the compensation committee of the Company’s board of directors granted a newly hired Executive Vice President an option to buy 150,000 shares of the Company’s common stock with a per share exercise price of $18.09, the closing trading price on the grant date, and 10,000 restricted stock units.

Improved screening practices could decrease disparities by increasing referrals for developmental delays in traditionally underserved communities

Service Corporation International (NYSE: SCI) announced it expects to issue a press release with financial results for the third quarter 2020 on Wednesday, October 28, 2020 , after the market closes. A conference call will be hosted by SCI Management on Thursday, October 29 , 2020. Details of the conference call are as follows: